Developmentally regulated expression of organic ion transporters NKT (OAT1), OCT1, NLT (OAT2), and Roct
about
Effects of perinatal PBDE exposure on hepatic phase I, phase II, phase III, and deiodinase 1 gene expression involved in thyroid hormone metabolism in male rat pupsThe organic anion transporter (OAT) family: a systems biology perspectiveTransport of organic anions and cations in murine embryonic kidney development and in serially-reaggregated engineered kidneysHepatocyte nuclear factor 1 regulates the expression of the organic cation transporter 1 via binding to an evolutionary conserved region in intron 1 of the OCT1 geneOrganic anion and cation SLC22 "drug" transporter (Oat1, Oat3, and Oct1) regulation during development and maturation of the kidney proximal tubuleA role for Timeless in epithelial morphogenesis during kidney developmentTemporal expression profiles of organic anion transport proteins in placenta and fetal liver of the ratEEG1, a putative transporter expressed during epithelial organogenesis: comparison with embryonic transporter expression during nephrogenesis.Organic anion and cation transporter expression and function during embryonic kidney development and in organ culture modelsThe organic anion transporter family: from physiology to ontogeny and the clinic.Analysis of three-dimensional systems for developing and mature kidneys clarifies the role of OAT1 and OAT3 in antiviral handlingRemote communication through solute carriers and ATP binding cassette drug transporter pathways: an update on the remote sensing and signaling hypothesis.Functional maturation of drug transporters in the developing, neonatal, and postnatal kidney.Deletion of multispecific organic anion transporter Oat1/Slc22a6 protects against mercury-induced kidney injury.Human Ontogeny of Drug Transporters: Review and Recommendations of the Pediatric Transporter Working GroupMolecular and cellular physiology of renal organic cation and anion transport.Generation and Characterisation of a Pax8-CreERT2 Transgenic Line and a Slc22a6-CreERT2 Knock-In Line for Inducible and Specific Genetic Manipulation of Renal Tubular Epithelial Cells.Handling of Drugs, Metabolites, and Uremic Toxins by Kidney Proximal Tubule Drug Transporters.What do drug transporters really do?Folic acid reverses uric acid crystal-induced surface OAT1 internalization by inhibiting RhoA activity in uric acid nephropathy.Effects of drug transporters on volume of distribution.Analysis of a large cluster of SLC22 transporter genes, including novel USTs, reveals species-specific amplification of subsets of family membersToward a systems level understanding of organic anion and other multispecific drug transporters: a remote sensing and signaling hypothesis.Nonclinical pharmacokinetics of oseltamivir and oseltamivir carboxylate in the central nervous system.The drug transporter OAT3 (SLC22A8) regulates endogenous metabolite flow through the gut-liver-kidney axis.Glutaric aciduria type 1 metabolites impair the succinate transport from astrocytic to neuronal cellsAn Organic Anion Transporter 1 (OAT1)-centered Metabolic Network.Elucidation of common pharmacophores from analysis of targeted metabolites transported by the multispecific drug transporter-Organic anion transporter1 (Oat1).
P2860
Q24655695-8BC7BD64-418D-4A04-BD27-86F95F35CF2EQ28085671-54728AAE-C3E7-4261-93A8-A51500976A00Q28258773-470BC387-AE9E-4337-AB1E-FE91431A24A1Q28296115-82510952-5C17-4CEE-80AF-4274D349B0BBQ28481309-77A2253B-0779-45DF-B6E7-1A6CF4D0DAA0Q28567875-FC29778E-3F12-4E65-8594-08425935E7B3Q28568887-AF1A8746-6A57-4E80-90BF-08005EA21EC1Q30665442-2C068F1E-9EDC-4F7A-9BF1-D7D2EF0757A6Q33674894-2EB9A3C5-EC78-4881-AF25-67AD5D199152Q34310328-53002178-23A3-4D35-BAD9-5CBFD0B3A2EAQ34452514-ADE5E979-0B80-404B-BA69-A7951524E159Q34865706-D9B30165-7D0E-456F-9883-1562E68AF019Q35080483-F46D3741-E60A-4416-816F-C074333B4510Q35128143-B439160D-1896-4C8D-915E-58F5C591D860Q35667919-46FF61F8-9D42-41BD-860E-0BFD344BF1ACQ35842999-AC1F529C-9D2F-4578-A7BF-A7D0420A3CBCQ35920812-64FE40E2-7378-4AF0-98C2-810EAF8A8991Q36250282-73FF8747-625F-4EB9-9E49-8967F315F155Q36571217-0D08B917-BB64-4F71-8407-70C0754C0C74Q36624084-B43F6CFB-0254-42AB-AD44-E4BE61DC2CF5Q37214523-9E6FAE9F-67A9-4BDE-B8F3-F310EF218EB0Q37265749-1F2C7AF2-9A09-4012-B8CA-6919540F6377Q37314370-4BEC712E-681C-4BC9-B14E-7ADDFA13F249Q37409972-71601F0B-7AFE-43B2-ADD9-374A09B88F55Q38648038-B122601F-B03B-43E2-9E29-9DDCA1FEF072Q39567176-3C4E173D-5138-4E30-A878-44E2F49D610DQ39579026-16A59791-849F-46C4-A97D-508238CC2BDBQ41982492-E3499C7B-D868-4083-8DAD-5FDABDDEB967
P2860
Developmentally regulated expression of organic ion transporters NKT (OAT1), OCT1, NLT (OAT2), and Roct
description
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2000
@ast
im April 2000 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2000/04/01)
@sk
vědecký článek publikovaný v roce 2000
@cs
wetenschappelijk artikel (gepubliceerd op 2000/04/01)
@nl
наукова стаття, опублікована у квітні 2000
@uk
مقالة علمية (نشرت في أبريل 2000)
@ar
name
Developmentally regulated expr ...... 1), OCT1, NLT (OAT2), and Roct
@ast
Developmentally regulated expr ...... 1), OCT1, NLT (OAT2), and Roct
@en
Developmentally regulated expr ...... 1), OCT1, NLT (OAT2), and Roct
@nl
type
label
Developmentally regulated expr ...... 1), OCT1, NLT (OAT2), and Roct
@ast
Developmentally regulated expr ...... 1), OCT1, NLT (OAT2), and Roct
@en
Developmentally regulated expr ...... 1), OCT1, NLT (OAT2), and Roct
@nl
prefLabel
Developmentally regulated expr ...... 1), OCT1, NLT (OAT2), and Roct
@ast
Developmentally regulated expr ...... 1), OCT1, NLT (OAT2), and Roct
@en
Developmentally regulated expr ...... 1), OCT1, NLT (OAT2), and Roct
@nl
P2093
P2860
P921
P1476
Developmentally regulated expr ...... 1), OCT1, NLT (OAT2), and Roct
@en
P2093
A. Pavlova
B. Leclercq
D. R. Beier
H. Sakurai
S. K. Nigam
P2860
P304
P356
10.1152/AJPRENAL.2000.278.4.F635
P577
2000-04-01T00:00:00Z